Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Apds Telehealth topic
No spam. Unsubscribe anytime.
Board debate over automated dispensing kiosks centers on whether telehealth patients qualify
Summary
During a prolonged licensing‑committee discussion, public commenters and industry groups urged the California State Board of Pharmacy to confirm that patients managed via telehealth by a medical practice can receive medications from that practice’s automated patient dispensing system (APDS); the committee said statute appears ambiguous and that definitive clarification will likely require rulemaking.
The California State Board of Pharmacy Licensing Committee spent a large portion of its April 15 meeting debating when and where automated patient dispensing systems (APDS) may be placed and whether patients treated via telehealth count as "patients of the practice" eligible to receive medications from an APDS.
The issue centers on Business and Professions Code language allowing an APDS to be “located and operated in a medical office or other location where patients are regularly seen for purposes of diagnosis and treatment” and to be used to dispense drugs “to patients of the practice.” Industry groups and vendors urged a permissive interpretation. "Telemedicine is medical care," said Hunter Young of ATA Action, asking the board to confirm that telehealth‑managed patients should have the same access to APDS as in‑person patients. Tony E., a pharmacist representing Same Day Healthcare Pharmacy, described a kiosk model that “integrates both tele medicine and telephary into a single kiosk, bringing care directly into the communities for the people that live there.”
Trade groups and clinics pressed the committee on two related points: first, that the statute does not distinguish how a patient was seen (in person versus virtually) and therefore the APDS location sentence applies regardless of visit modality; second, that staff communications appeared to require monthly in‑person pharmacist inspections for APDS in medical offices — a requirement commenters said is not found in the statute. "Leaving ambiguity here risks creating an unintended gap where telehealth patients face barriers to medication access that their in‑person counterparts do not," said Sarah Palomu of the California Retailers Association and California Community Pharmacy Coalition.
Committee members and counsel repeatedly said the statutory language is ambiguous. Chair Son Oo told the room that, while the committee hears the strong public interest in enabling APDS access for telehealth patients, the board cannot unilaterally rewrite unclear statutory text in a committee meeting and that formal rulemaking may be required for definitive resolution. "The statute unfortunately is not clear," she said, noting Office of Administrative Law (OAL) determinations on other AB 1503 implementation items that also forced formal rulemaking rather than streamlined fixes.
Commenters supplied operational details the committee said would be useful for rule drafting and guidance. Industry speakers requested clarity on whether APDS inspections may rely on remote supervision or pharmacy‑staffed oversight rather than a monthly in‑person pharmacist check, and asked the board to specify allowable locations (for example, secure telehealth kiosks in clinics versus open public lockers). Emily How, a pharmacist commenting for technology‑enabled pharmacies, urged the committee to permit practices to "leverage technology and pharmacy staff like pharmacy technicians to provide this support and oversight consistent with how the board has already approached remote processing."
The committee did not adopt new guidance at the meeting. Several members said they would ask staff and counsel to draft proposed regulatory language and bring the issue back to the full board for consideration. Chair Oo also signaled the board would try to clarify the status of inspection frequency and explained that any broader change in who may be served by APDS likely requires formal rulemaking and public notice.
What happens next: The committee directed staff to coordinate with legal counsel and inspectors to clarify which inspection requirements already apply to APDS in medical offices and to consider whether regulatory language is needed to specify allowed locations and patient eligibility. Members asked the public and stakeholders to submit written examples of APDS models and proposed safeguards to help staff draft potential rule language.
